Literature DB >> 19131007

Left atrial volume provides independent prognostic value in patients with Chagas cardiomyopathy.

Maria Carmo P Nunes1, Marcia M Barbosa, Antônio Luiz P Ribeiro, Enrico A Colosimo, Manoel O C Rocha.   

Abstract

BACKGROUND: Heart failure is a severe clinical manifestation of Chagas disease. Left atrial volume (LAV), a marker of chronically elevated left ventricular (LV) filling pressure, is a predictor of prognosis in patients with heart failure and may be important in the assessment of risk in patients with Chagas disease. The aim of this study was to identify echocardiographic parameters of diastolic function predictors of survival in patients with Chagas cardiomyopathy.
METHODS: A total of 192 patients with Chagas cardiomyopathy (mean age, 48.5 +/- 12.1 years; 37% women) were prospectively enrolled. The end points were death and cardiac transplantation.
RESULTS: Over a mean follow-up period of 33.8 months, LAV normalized for body surface area emerged as an independent predictor of survival (hazard ratio, 1.037 per 1 mL/m(2) change; 95% confidence interval, 1.018-1.056; P < .001), adding incremental prognostic value to clinical factors, LV ejection fraction, and Doppler-derived parameters of diastolic function. Receiver operating characteristic curve analysis identified the best cutoff values for the prediction of end points. LAV > 51 mL/m(2) was associated with significant excess mortality (log-rank, P < .001).
CONCLUSIONS: LAV provides powerful prognostic information incrementally and independently to clinical data and conventional echocardiographic parameters in the prediction of survival. New York Heart Association functional class, LV ejection fraction, right ventricular function, the E/E' ratio, and LAV index can be used to build a risk prediction model, which can be used clinically.

Entities:  

Mesh:

Year:  2009        PMID: 19131007     DOI: 10.1016/j.echo.2008.11.015

Source DB:  PubMed          Journal:  J Am Soc Echocardiogr        ISSN: 0894-7317            Impact factor:   5.251


  15 in total

1.  Prognostic value of real-time three-dimensional echocardiography compared to two-dimensional echocardiography in patients with systolic heart failure.

Authors:  Frederico J N Mancuso; Valdir A Moises; Dirceu R Almeida; Dalva Poyares; Luciana J Storti; Flavio S Brito; Sergio Tufik; Angelo A V de Paola; Antonio C C Carvalho; Orlando Campos
Journal:  Int J Cardiovasc Imaging       Date:  2017-11-02       Impact factor: 2.357

2.  Echocardiographic parameters and survival in Chagas heart disease with severe systolic dysfunction.

Authors:  Daniela do Carmo Rassi; Marcelo Luiz Campos Vieira; Ana Lúcia Martins Arruda; Viviane Tiemi Hotta; Rogério Gomes Furtado; Danilo Teixeira Rassi; Salvador Rassi
Journal:  Arq Bras Cardiol       Date:  2014-02-10       Impact factor: 2.000

Review 3.  Diagnosis and management of Chagas disease and cardiomyopathy.

Authors:  Antonio L Ribeiro; Maria P Nunes; Mauro M Teixeira; Manoel O C Rocha
Journal:  Nat Rev Cardiol       Date:  2012-07-31       Impact factor: 32.419

Review 4.  Clinical and echocardiographic predictors of mortality in chagasic cardiomyopathy--systematic review.

Authors:  Clodoval de Barros Pereira Júnior; Brivaldo Markman Filho
Journal:  Arq Bras Cardiol       Date:  2014-06-06       Impact factor: 2.000

5.  Comparison of area-length method by echocardiography versus full-volume quantification by cardiac magnetic resonance imaging for the assessment of left atrial volumes in children, adolescents, and young adults.

Authors:  Peace C Madueme; Wojciech Mazur; Kan N Hor; Joshua T Germann; John L Jefferies; Michael D Taylor
Journal:  Pediatr Cardiol       Date:  2013-11-17       Impact factor: 1.655

6.  Prevalence of Chagas heart disease in a region endemic for Trypanosoma cruzi: evidence from a central Bolivian community.

Authors:  Jessica E Yager; Daniel F Lozano Beltran; Faustino Torrico; Robert H Gilman; Caryn Bern
Journal:  Glob Heart       Date:  2015-09

Review 7.  Chagas Cardiomyopathy: From Romaña Sign to Heart Failure and Sudden Cardiac Death.

Authors:  Antonia Pino-Marín; Germán José Medina-Rincón; Sebastian Gallo-Bernal; Alejandro Duran-Crane; Álvaro Ignacio Arango Duque; María Juliana Rodríguez; Ramón Medina-Mur; Frida T Manrique; Julian F Forero; Hector M Medina
Journal:  Pathogens       Date:  2021-04-22

8.  Incidence and Predictors of Progression to Chagas Cardiomyopathy: Long-Term Follow-Up of Trypanosoma cruzi-Seropositive Individuals.

Authors:  Maria Carmo P Nunes; Lewis F Buss; Antonio Luiz P Ribeiro; Ester Cerdeira Sabino; Jose Luiz P Silva; Larissa Natany A Martins; Claudia Di Lorenzo Oliveira; Clareci Silva Cardoso; Bruno Oliveira de Figueiredo Brito; Ariela Mota Ferreira; Lea Campos Oliveira; Ana Luiza Bierrenbach; Fabio Fernandes; Michael P Busch; Viviane Tiemi Hotta; Luiz Mario Baptista Martinelli; Maria Carolina F Almeida Soeiro; Adriana Brentegani; Vera M C Salemi; Marcia M Menezes
Journal:  Circulation       Date:  2021-09-27       Impact factor: 29.690

9.  Left Atrial Volume Determinants in Patients with Non-Ischemic Dilated Cardiomyopathy.

Authors:  Frederico José Neves Mancuso; Valdir Ambrósio Moisés; Dirceu Rodrigues Almeida; Dalva Poyares; Luciana Julio Storti; Wércules Antonio Oliveira; Flavio Souza Brito; Angelo Amato Vincenzo de Paola; Antonio Carlos Camargo Carvalho; Orlando Campos
Journal:  Arq Bras Cardiol       Date:  2015-05-08       Impact factor: 2.000

10.  Automated quantification of left atrial size using three-beat averaging real-time three dimensional Echocardiography in patients with atrial fibrillation.

Authors:  Ran Heo; Geu-Ru Hong; Young-Jin Kim; Joel Mancina; In-Jeong Cho; Chi Young Shim; Hyuk-Jae Chang; Jong-Won Ha; Namsik Chung
Journal:  Cardiovasc Ultrasound       Date:  2015-08-25       Impact factor: 2.062

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.